Sitagliptin and metformin
- Generic Name
- Sitagliptin and metformin
- Brand Names
- -
- Drug Type
- -
- Chemical Formula
- -
- CAS Number
- -
- Unique Ingredient Identifier
- -
- Indication
临床用于二甲双胍单药治疗血糖仍控制不佳或正在接受二者联合治疗的2型糖尿病患者，应用任何降血糖药物的同时应配合饮食和运动治疗，方可达到满意的临床效果。
- Associated Conditions
- -
- Associated Therapies
- -
Non-alcoholic Fatty Liver Disease and Its Treatment
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2022-07-29
- Last Posted Date
- 2022-07-29
- Lead Sponsor
- Shanghai 10th People's Hospital
- Target Recruit Count
- 68
- Registration Number
- NCT05480007
Weight Maintenance With Dipeptidyl Peptidase 4 (DPP4) Inhibitor Sitagliptin in Combination With Metformin After Liragludite Induced Weight Loss
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2016-10-21
- Last Posted Date
- 2016-10-21
- Lead Sponsor
- University Medical Centre Ljubljana
- Target Recruit Count
- 24
- Registration Number
- NCT02941445
Treatment of Wolfram Syndrome Type 2 With the Chelator Deferiprone and Incretin Based Therapy
- First Posted Date
- 2016-08-29
- Last Posted Date
- 2016-08-29
- Lead Sponsor
- Hadassah Medical Organization
- Target Recruit Count
- 20
- Registration Number
- NCT02882477
- Locations
- 🇮🇱
Hadassah medical center, Jerusalem, Israel
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath